Ok Biotech Co Ltd
OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring systems and homecare healthcare devices in Taiwan and internationally. It also offers OTC hearing aids, multi-frequency therapy devices, and factory setup solutions. The company was founded in 2004 and is based in Hsinchu City, Taiwan.
Ok Biotech Co Ltd (4155) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.019x
Based on the latest financial reports, Ok Biotech Co Ltd (4155) has a cash flow conversion efficiency ratio of 0.019x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$47.74 Million) by net assets (NT$2.52 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ok Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Ok Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ok Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ok Biotech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hai Phong Hoang Ha Paper JSC
VN:HHP
|
N/A |
|
INTRED S.P.A.
F:M7P
|
N/A |
|
Doxa AB
ST:DOXA
|
0.055x |
|
Blackboxstocks Inc
NASDAQ:BLBX
|
-0.200x |
|
Kunyue Development Co Ltd
TWO:5206
|
-0.329x |
|
Twinhead International Corp
TW:2364
|
0.144x |
|
Precision System Science Co. Ltd.
PINK:PCNEF
|
-0.046x |
|
Southeastern Banking Corp
PINK:SEBC
|
0.013x |
Annual Cash Flow Conversion Efficiency for Ok Biotech Co Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of Ok Biotech Co Ltd from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$2.57 Billion | NT$65.90 Million | 0.026x | +1996.54% |
| 2023-12-31 | NT$2.40 Billion | NT$2.93 Million | 0.001x | -99.06% |
| 2022-12-31 | NT$1.85 Billion | NT$240.53 Million | 0.130x | +913.18% |
| 2021-12-31 | NT$1.70 Billion | NT$21.90 Million | 0.013x | -84.86% |
| 2020-12-31 | NT$1.74 Billion | NT$147.70 Million | 0.085x | +144.78% |
| 2019-12-31 | NT$1.30 Billion | NT$45.18 Million | 0.035x | -65.83% |
| 2018-12-31 | NT$1.27 Billion | NT$128.75 Million | 0.102x | +19.16% |
| 2017-12-31 | NT$1.21 Billion | NT$102.77 Million | 0.085x | -69.12% |
| 2016-12-31 | NT$944.80 Million | NT$260.72 Million | 0.276x | -9.41% |
| 2015-12-31 | NT$950.15 Million | NT$289.44 Million | 0.305x | +864.81% |
| 2014-12-31 | NT$849.48 Million | NT$-33.83 Million | -0.040x | -127.88% |
| 2013-12-31 | NT$609.65 Million | NT$87.08 Million | 0.143x | -18.43% |
| 2012-12-31 | NT$452.10 Million | NT$79.17 Million | 0.175x | -42.99% |
| 2011-12-31 | NT$303.11 Million | NT$93.12 Million | 0.307x | +463.30% |
| 2010-12-31 | NT$230.78 Million | NT$-19.52 Million | -0.085x | -247.52% |
| 2009-12-31 | NT$121.25 Million | NT$6.95 Million | 0.057x | -- |